- Home
- Publications
- Publication Search
- Publication Details
Title
The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 8, Pages 1126
Publisher
MDPI AG
Online
2019-08-07
DOI
10.3390/cancers11081126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Polyamine Metabolism as a Therapeutic Target in Hedgehog-Driven Basal Cell Carcinoma and Medulloblastoma
- (2019) Sonia Coni et al. Cells
- A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer
- (2018) M. Rudolph et al. BREAST CANCER RESEARCH AND TREATMENT
- Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer
- (2018) Syeda Kiran Riaz et al. Cell Communication and Signaling
- Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
- (2018) Michael R. Savona et al. CLINICAL CANCER RESEARCH
- A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors
- (2018) Hideki Ueno et al. INVESTIGATIONAL NEW DRUGS
- A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study
- (2018) Manuel Ruiz-Borrego et al. INVESTIGATIONAL NEW DRUGS
- Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
- (2018) Sherona R. Sirkisoon et al. ONCOGENE
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
- (2018) Małgorzata Szostakowska et al. BREAST CANCER RESEARCH AND TREATMENT
- GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma
- (2018) Zhaoting Yang et al. EXPERIMENTAL CELL RESEARCH
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer
- (2018) Ann Hanna et al. OncoImmunology
- Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
- (2018) Ita Novita Sari et al. Cells
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells
- (2017) Yoshikazu Koike et al. Breast Cancer
- EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells
- (2017) Deepika Neelakantan et al. Nature Communications
- Triple negative breast cancer: the kiss of death
- (2017) Adriana-Andreea Jitariu et al. Oncotarget
- Practical Approach to Triple-Negative Breast Cancer
- (2017) Vijayakrishna K. Gadi et al. Journal of Oncology Practice
- 445ODOSE-ESCALATION STUDY OF SONIDEGIB (LDE225) PLUS BUPARLISIB (BKM120) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
- (2017) Q.S. Chu et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
- (2016) Xiaoxian Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Emerging from their burrow: Hedgehog pathway inhibitors for cancer
- (2016) Gregory N. Gan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
- (2016) Monica Benvenuto et al. Oncotarget
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh
- (2016) A. S. Noman et al. Scientific Reports
- Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
- (2015) M Zuo et al. BRITISH JOURNAL OF CANCER
- Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy
- (2015) Li Song et al. CANCER BIOLOGY & THERAPY
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer
- (2015) C. M. Della Corte et al. CLINICAL CANCER RESEARCH
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- p63 sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling
- (2015) Elisa Maria Memmi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
- (2015) Annelies Gonnissen et al. Oncotarget
- FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer
- (2015) Bingchen Han et al. Cell Reports
- Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
- (2015) Komaraiah Palle et al. Cancers
- Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth
- (2014) Laura Di Magno et al. CELL CYCLE
- Sonic Hedgehog Paracrine Signaling Activates Stromal Cells to Promote Perineural Invasion in Pancreatic Cancer
- (2014) X. Li et al. CLINICAL CANCER RESEARCH
- CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance
- (2014) C. Yoon et al. CLINICAL CANCER RESEARCH
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation
- (2014) Ying Sun et al. Molecular Cancer
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
- (2014) Fritz Aberger et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Hedgehog Signaling Pathway and Cancer Therapeutics: Progress to Date
- (2013) Joshua M. Ruch et al. DRUGS
- GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
- (2013) Hira Lal Goel et al. EMBO Molecular Medicine
- Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition
- (2013) Shamik Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gli Activity Is Critical at Multiple Stages of Embryonic Mammary and Nipple Development
- (2013) Anupama Chandramouli et al. PLoS One
- Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog–Gli1 pathway
- (2012) Linlin Zhang et al. CANCER LETTERS
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer
- (2011) S. A. O'Toole et al. CANCER RESEARCH
- TGF- /SMAD/GLI2 Signaling Axis in Cancer Progression and Metastasis
- (2011) D. Javelaud et al. CANCER RESEARCH
- Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines
- (2011) Yeon-Jin Kwon et al. CLINICAL & EXPERIMENTAL METASTASIS
- Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells
- (2011) X Cao et al. ONCOGENE
- Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy
- (2011) Ciara S. O’Brien et al. Hormones & Cancer
- p63in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
- (2010) Christopher P. Crum et al. Annual Review of Pathology-Mechanisms of Disease
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer
- (2010) Masae Souzaki et al. CANCER SCIENCE
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer
- (2009) Lusheng Xu et al. BREAST CANCER RESEARCH AND TREATMENT
- Development of Mammary Tumors by Conditional Expression of GLI1
- (2009) M. Fiaschi et al. CANCER RESEARCH
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway
- (2009) Harald Schnidar et al. CANCER RESEARCH
- Therapeutic Inhibition of Hedgehog-GLI Signaling in Cancer: Epithelial, Stromal, or Stem Cell Targets?
- (2008) Ariel Ruiz i Altaba CANCER CELL
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started